查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
植物原料药市场 - 2018-2028 年全球行业规模、份额、趋势、机会和预测，按类型、按应用、地区和竞争细分
市场调查报告书
商品编码
1326470

植物原料药市场 - 2018-2028 年全球行业规模、份额、趋势、机会和预测，按类型、按应用、地区和竞争细分

Plant Based API Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented By Type, By Application, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 111 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

由于消费者对天然和可持续产品的需求不断增长，预计全球植物原料药市场在预测期内将以惊人的速度增长。许多消费者越来越意识到他们使用的产品对环境的影响，并越来越多地寻求天然和可持续的替代品。因此，许多製药公司现在转向植物原料药来满足这一需求并在市场中脱颖而出，从而支持全球植物原料药市场的增长。

人们对植物药物的兴趣日益浓厚

传统医学长期以来依赖植物的治疗特性，许多自然疗法已被证明可以有效治疗多种疾病。因此，人们对植物基药物的开发越来越感兴趣，而植物基 API 是这一趋势的关键组成部分。这反过来又促进了各种植物药物的开发，从而推动了全球植物活性药物成分（API）市场的增长。例如，2018 年，美国食品和药物管理局 (FDA) 批准了 Epidiolex，这是一种由大麻二酚 (CBD) 製成的药物，大麻二酚是一种在大麻植物中发现的化合物。该药物用于治疗两岁及以上患者的两种罕见形式的癫痫，Lennox-Gastaut 综合征和 Dravet 综合征。 Epidiolex 的批准标誌着植物基药物在西药中使用的一个重要里程碑。同样，2020年，FDA批准了Sutimlimab（一种由烟草植物製成的单克隆抗体）用于治疗成年冷凝集素病（CAD）患者的溶血。 Sutimlimab是第一个获得FDA批准的植物源单克隆抗体，是利用植物源药物治疗罕见疾病的重要一步。此外，2020 年，FDA 批准了 Ferriprox，一种铁螯合剂，用于治疗输血铁超负荷患者。 Ferriprox 由一种称为去铁酮的植物化合物製成，该化合物源自一种称为黄热病树的植物。 Ferriprox 的批准为输血铁超负荷患者提供了一种新的治疗选择，这种情况可能发生在地中海贫血、镰状细胞性贫血和其他血液疾病患者中。

人们对植物性药物的兴趣日益浓厚，加上对植物性产品的需求不断增长，肯定也会增加对植物性活性药物成分的需求，从而支持全球植物性 API 市场的增长。

慢性病患病率增加

癌症、糖尿病和心脏病等慢性疾病正在增加，对新的有效治疗方法的需求日益增长。植物原料药已被证明具有广泛的健康益处，包括抗炎和抗氧化特性，并被用于生产多种药物。这反过来又促进了几种用于治疗这些慢性病的药物或疗法的植物基版本的推出，从而为未来几年全球植物基 API 市场的增长创造了新的前景。例如，紫杉醇是一种化疗药物，用于治疗各种癌症，包括乳腺癌、卵巢癌和肺癌。 2020年，植物基紫杉醇在印度上市。这种植物性版本是由紫杉树製成的，几个世纪以来，紫杉树一直被用来治疗各种疾病。植物基紫杉醇被认为比传统合成紫杉醇更具可持续性，因为它是使用可再生资源生产的。同样，地高辛是一种用于治疗心力衰竭和某些心律失常的药物。 2021 年，植物基版本的地高辛在印度上市。植物性版本是由一种叫做毛地黄的植物製成的，这种植物已经在传统医学中使用了几个世纪。植物性地高辛被视为比使用石化产品生产的合成地高辛更可持续的替代品。

生物技术和基因组学的进展

基因组学和生物技术的进步使得能够鑑定和分离负责在植物中产生活性化合物的特定基因。这导致了能够产生更多活性化合物的新植物品种的开发，这些化合物可用于开发新的植物原料药，从而支持全球植物原料药市场的增长。这也吸引了全球各大大小公司的关注，纷纷投资该领域，从而支持全球植物原料药市场的增长。例如，以色列生物技术公司 Kaiima Bio-Agritech 开发了一个作物遗传改良平台，用于生产高价值的植物原料药，而加拿大生物技术公司 Ceapro 开发了一种从植物中提取活性成分的专有技术用于药品和其他产品。

最近的发展

  • 2019 年，威斯康星大学麦迪逊分校的一组研究人员开发了一个新平台，利用转基因烟草植物生产植物原料药。研究人员能够在烟草植物中产生一种名为白介素 37 (IL-37) 的抗炎蛋白，并证明该蛋白能够减轻小鼠炎症性肠病的症状。
  • 2019年，赛诺菲公司宣布对其法国生产基地投资6.4亿美元（6亿欧元），重点关注用于治疗罕见疾病的植物原料药。该投资将支持新植物技术的开发，包括利用藻类和其他微生物生产 API。赛诺菲还投资生产植物胰岛素，并于 2020 年获得 FDA 批准。
  • 近年来，诺华还在植物原料药领域进行了大量投资，重点是植物细胞培养技术的使用。 2020年，诺华宣布与加拿大生物技术公司PlantForm Corporation合作开髮用于治疗罕见疾病的植物生物仿製药。诺华还投资了植物疫苗的开发，包括与波士顿生物技术公司 VBI Vaccines 合作开发针对 COVID-19 的植物疫苗。
  • 2020年，总部位于加州的生物技术公司Amyris宣布，已成功生产出植物基版本的抗疟疾药物青蒿素。该公司使用专有的酵母菌株来生产该药物，然后授权给製药公司进行进一步开发和商业化。
  • 2021年，布里斯託大学的研究人员开发了一种使用转基因酵母生产疟疾药物青蒿素关键成分的方法。这种方法为传统的药物生产方法（涉及从艾蒿植物中提取药物）提供了一种更可持续且更具成本效益的替代方案

可用的定制：

根据给定的市场数据，TechSci Research 可根据公司的具体需求提供定制服务。该报告可以使用以下自定义选项：

公司信息

  • 其他市场参与者（最多五个）的详细分析和概况分析。

目录

第 1 章：产品概述

  • 市场定义
  • 市场范围
    • 涵盖的市场
    • 考虑学习的年份
    • 主要市场细分

第 2 章：研究方法

  • 研究目的
  • 基线方法
  • 主要行业合作伙伴
  • 主要协会和二手资料来源
  • 预测方法
  • 数据三角测量和验证
  • 假设和限制

第 3 章：执行摘要

  • 市场概况
  • 主要市场细分概述
  • 主要市场参与者概述
  • 重点地区/国家概况
  • 市场驱动因素、挑战、趋势概述

第 4 章：客户之声

第 5 章：全球植物原料药市场展望

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 按类型（生物碱、花青素、黄酮类、酚酸、萜类化合物、木脂素和芪等）
    • 按应用（药品、保健品、草药工业、其他）
    • 按地区
    • 按公司划分 (2022)
  • 产品图
    • 按类型
    • 按应用
    • 按地区

第 6 章：北美植物原料药市场展望

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 按类型
    • 按应用
    • 按国家/地区
  • 北美：国家分析
    • 美国
    • 加拿大
    • 墨西哥

第 7 章：欧洲植物原料药市场展望

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 按类型
    • 按应用
    • 按国家/地区
  • 欧洲：国家分析
    • 法国
    • 德国
    • 英国
    • 意大利
    • 西班牙

第 8 章：亚太地区植物原料药市场展望

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 按类型
    • 按应用
    • 按国家/地区
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳大利亚

第 9 章：南美植物原料药市场展望

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 按类型
    • 按应用
    • 按国家/地区
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第 10 章：中东和非洲植物原料药市场展望

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 按类型
    • 按应用
    • 按国家/地区
  • MEA：国家分析
    • 南非植物原料药
    • 沙特阿拉伯 植物原料药
    • 阿联酋植物原料药

第 11 章：市场动态

  • 司机
  • 挑战

第 12 章：市场趋势与发展

  • 近期发展
  • 併购
  • 产品发布

第 13 章：全球植物原料药市场：SWOT 分析

第 14 章：波特的五力分析

  • 行业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 客户的力量
  • 替代产品的威胁

第15章：竞争格局

  • 商业概览
  • 产品供应
  • 最近的发展
  • 主要人员
  • SWOT分析
    • Roquette Freres SA
    • EVONIK Industries, AG
    • Cargill, Inc.
    • Kothari Phytochemicals & Industries Ltd
    • Medipure Pharmaceuticals Inc.
    • Centroflora Group
    • Arboris, LLCs
    • BASF SE
    • Novartis AG
    • Sanofi SA
    • GlaxoSmithKline, plc
    • F. Hoffmann-La Roche AG

第 16 章：战略建议

简介目录
Product Code: 14866

Global Plant Based API Market is expected to grow at an impressive rate during the forecast period on account of the growing consumer demand for natural and sustainable products. Many consumers are becoming more conscious of the environmental impact of the products they use and are increasingly seeking out natural and sustainable alternatives. As a result, many pharmaceutical companies are now turning to plant-based APIs to meet this demand and differentiate themselves in the market, thereby supporting the growth of global plant based API market.

Plant-based APIs are derived from natural sources, such as herbs, spices, and other plants, and are used to produce a wide range of pharmaceuticals, including antibiotics, painkillers, and anticancer drugs. The growing demand for eco friendly products and need to achieve sustainability goals among countries and governments worldwide will create lucrative opportunities for the growth of global plant based API market in the next few years.

Another driver of the global plant-based API market is the growing interest in plant-based medicines. Traditional medicine has long relied on the healing properties of plants, and many of these natural remedies have been shown to be effective in treating a wide range of ailments. As a result, there is growing interest in the development of plant-based medicines, and plant-based APIs are a key component of this trend.

Growing Interest in Plant Based Medicines

Traditional medicine has long relied on the healing properties of plants, and many of these natural remedies have been shown to be effective in treating a wide range of ailments. As a result, there is a growing interest in the development of plant-based medicines, and plant-based APIs are a key component of this trend. This has in turn led to the development of various plant based pharmaceuticals thereby driving the growth of global plant based active pharmaceutical ingredient (API) market. For instance, in 2018, the U.S. Food and Drug Administration (FDA) approved Epidiolex, a drug made from cannabidiol (CBD), a compound found in the cannabis plant. This drug is used to treat two rare forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, in patients two years of age and older. The approval of Epidiolex marked a significant milestone in the use of plant-based pharmaceuticals in Western medicine. Similarly, in 2020, the FDA approved Sutimlimab, a monoclonal antibody made from tobacco plants, for the treatment of hemolysis in adult patients with cold agglutinin disease (CAD). Sutimlimab is the first plant-based monoclonal antibody to receive FDA approval, and it is a significant step forward in the use of plant-based pharmaceuticals for the treatment of rare diseases. Additionally, in 2020, the FDA approved Ferriprox, an iron chelator used to treat patients with transfusional iron overload. Ferriprox is made from a plant-based compound called deferiprone, which is derived from a plant called the yellow fever tree. The approval of Ferriprox provides a new treatment option for patients with transfusional iron overload, which can occur in patients with thalassemia, sickle cell anemia, and other blood disorders.

The increasing interest in plant based pharmaceuticals along with growing demand for plant based products will certainly increase the demand for plant based active pharmaceutical ingredients as well, thereby supporting the growth of global plant based API market.

Increasing Prevalence of Chronic Diseases

Chronic diseases such as cancer, diabetes, and heart disease are on the rise, and there is a growing need for new and effective treatments. Plant based APIs have been shown to have a wide range of health benefits, including anti-inflammatory and antioxidant properties, and are being used to produce a wide range of pharmaceuticals. This has in turn contributed to the launch of plant based versions of several medicine or therapies that are used to treat these chronic conditions, thereby creating new prospects for the growth of global plant based API market in the next few years. For instance, Paclitaxel is a chemotherapy drug used to treat various cancers, including breast, ovarian, and lung cancer. In 2020, a plant-based version of paclitaxel was launched in India. This plant-based version is made from yew trees, which have been used for centuries to treat various ailments. The plant-based version of paclitaxel is considered to be more sustainable than the traditional synthetic version, as it is produced using renewable resources. Similarly, Digoxin is a medication used to treat heart failure and certain heart rhythm disorders. In 2021, a plant-based version of digoxin was launched in India. The plant-based version is made from a plant called Digitalis lanata, which has been used in traditional medicine for centuries. The plant-based version of digoxin is seen as a more sustainable alternative to the synthetic version, which is produced using petrochemicals.

Advances in Biotechnology and Genomics

The advancement in genomics and biotechnology has enabled the identification and isolation of specific genes responsible for the production of active compounds in plants. This has led to the development of new plant varieties that produce higher quantities of active compounds, which can be used to develop new plant-based APIs, thereby supporting the growth of global plant based API market. This has also attracted the focus of various small and big companies worldwide making investment into this space and hence supporting the growth of global plant based API market. For example, Israeli biotech company Kaiima Bio-Agritech has developed a platform for the genetic improvement of crops for the production of high-value plant-based APIs, while Canadian biotech company Ceapro has developed a proprietary technology for the extraction of active ingredients from plants for use in pharmaceuticals and other products.

Market Segmentation

Global Plant Based API Market can be segmented by type, by application, and by region. Based on type, the Global Plant Based API market can be categorized into alkaloids, anthocyanins, flavonoids, phenolic acids, terpenoids, lignans and stilbenes, and others. By application, the Global Plant Based API market can be fragmented into pharmaceuticals, nutraceuticals, herbal based industries, and others. Regionally, the Global Plant Based API market can be segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa.

Market Players

Roquette Freres SA, EVONIK Industries, AG, Cargill, Inc., Kothari Phytochemicals & Industries Ltd, Medipure Pharmaceuticals Inc., Centroflora Group, Arboris, LLCs, BASF SE, Novartis AG, Sanofi SA, GlaxoSmithKline, plc, F. Hoffmann-La Roche AG, among others are some of the leading players operating in the Global Plant Based API market.

Recent Developments

  • In 2019, a team of researchers from the University of Wisconsin-Madison developed a new platform for producing plant-based APIs using genetically modified tobacco plants. The researchers were able to produce an anti-inflammatory protein called Interleukin-37 (IL-37) in tobacco plants and demonstrated that the protein was able to alleviate symptoms of inflammatory bowel disease in mice.
  • In 2019, Sanofi SA announced a USD 640 million (€600 million) investment in its French production sites, with a focus on plant-based APIs for the treatment of rare diseases. The investment will support the development of new plant-based technologies, including the use of algae and other microorganisms to produce APIs. Sanofi has also invested in the production of plant-based insulin, which was approved by the FDA in 2020.
  • Novartis has also made significant investments in plant-based APIs in recent years, with a focus on the use of plant cell culture technology. In 2020, Novartis announced a collaboration with Canadian biotech company PlantForm Corporation to develop plant-based biosimilars for the treatment of rare diseases. Novartis has also invested in the development of plant-based vaccines, including a collaboration with Boston-based biotech company VBI Vaccines to develop a plant-based vaccine for COVID-19.
  • In 2020, Amyris, a California-based biotechnology company, announced that it had successfully produced a plant-based version of the anti-malarial drug artemisinin. The company used a proprietary yeast strain to produce the drug, which was then licensed to pharmaceutical companies for further development and commercialization.
  • In 2021, researchers from the University of Bristol developed a method for producing a key component of the malaria drug artemisinin using genetically modified yeast. This approach offers a more sustainable and cost-effective alternative to traditional methods of producing the drug, which involve extracting it from the artemisia plant

Report Scope:

In this report, Global Plant Based API Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Plant Based API Market, By Type:

  • Alkaloids
  • Anthocyanins
  • Flavonoids
  • Phenolic Acids
  • Terpenoids
  • Lignans and Stilbenes
  • Others

Plant Based API Market, By Application:

  • Pharmaceuticals
  • Nutraceuticals
  • Herbal Based Industries
  • Others

Plant Based API Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Plant Based API Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Plant Based API Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Alkaloids, Anthocyanins, Flavonoids, Phenolic Acids, Terpenoids, Lignans and Stilbenes, Others)
    • 5.2.2. By Application (Pharmaceuticals, Nutraceuticals, Herbal Based Industries, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2022)
  • 5.3. Product Map
    • 5.3.1. By Type
    • 5.3.2. By Application
    • 5.3.3. By Region

6. North America Plant Based API Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Plant Based API Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Plant Based API Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Plant Based API Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Application

7. Europe Plant Based API Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Plant Based API Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Application
    • 7.3.2. Germany Plant Based API Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom Plant Based API Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Plant Based API Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Plant Based API Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Application

8. Asia-Pacific Plant Based API Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Plant Based API Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Application
    • 8.3.2. India Plant Based API Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Application
    • 8.3.3. Japan Plant Based API Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Application
    • 8.3.4. South Korea Plant Based API Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Plant Based API Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Application

9. South America Plant Based API Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Plant Based API Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Application
    • 9.3.2. Argentina Plant Based API Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Application
    • 9.3.3. Colombia Plant Based API Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Application

10. Middle East and Africa Plant Based API Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Plant Based API Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Application
    • 10.3.2. Saudi Arabia Plant Based API Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Application
    • 10.3.3. UAE Plant Based API Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Plant Based API Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Product Offerings
  • 15.3. Recent Developments
  • 15.4. Key Personnel
  • 15.5. SWOT Analysis
    • 15.5.1. Roquette Freres SA
    • 15.5.2. EVONIK Industries, AG
    • 15.5.3. Cargill, Inc.
    • 15.5.4. Kothari Phytochemicals & Industries Ltd
    • 15.5.5. Medipure Pharmaceuticals Inc.
    • 15.5.6. Centroflora Group
    • 15.5.7. Arboris, LLCs
    • 15.5.8. BASF SE
    • 15.5.9. Novartis AG
    • 15.5.10. Sanofi SA
    • 15.5.11. GlaxoSmithKline, plc
    • 15.5.12. F. Hoffmann-La Roche AG

16. Strategic Recommendations